| 2023年年报 | 2022年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 动保添加剂及制剂(元) | 197,032,780.72 | 228,561,620.36 |
| 动保原料药(元) | 1,637,754,870.39 | 1,860,897,947.48 |
| 关键医药中间体(元) | 1,121,027,926.50 | 1,464,347,953.94 |
| 医药原料药(元) | 2,217,185,839.84 | 1,992,095,406.25 |
| 医药制剂(元) | 146,966,832.77 | 157,690,812.35 |
| 其他(元) | 7,129,457.70 | - |
| 营业成本(元) | ||
| 动保添加剂及制剂(元) | 177,230,151.29 | 196,505,234.95 |
| 动保原料药(元) | 1,299,094,278.60 | 1,485,500,598.91 |
| 关键医药中间体(元) | 739,307,574.45 | 832,149,430.01 |
| 医药原料药(元) | 1,736,435,384.12 | 1,483,823,029.40 |
| 医药制剂(元) | 128,885,115.99 | 143,152,365.20 |
| 其他(元) | 7,216,324.63 | - |
| 毛利(元) | ||
| 动保添加剂及制剂(元) | 19,802,629.43 | 32,056,385.41 |
| 动保原料药(元) | 338,660,591.79 | 375,397,348.57 |
| 关键医药中间体(元) | 381,720,352.05 | 632,198,523.93 |
| 医药原料药(元) | 480,750,455.72 | 508,272,376.85 |
| 医药制剂(元) | 18,081,716.78 | 14,538,447.15 |
| 其他(元) | -86,866.93 | - |
| 毛利率(%) | ||
| 动保添加剂及制剂(%) | 10.05 | 14.03 |
| 动保原料药(%) | 20.68 | 20.17 |
| 关键医药中间体(%) | 34.05 | 43.17 |
| 医药原料药(%) | 21.68 | 25.51 |
| 医药制剂(%) | 12.30 | 9.22 |
| 其他(%) | -1.22 | - |
| 收入构成(%) | ||
| 动保添加剂及制剂(%) | 3.70 | 4.01 |
| 动保原料药(%) | 30.74 | 32.63 |
| 关键医药中间体(%) | 21.04 | 25.67 |
| 医药原料药(%) | 41.62 | 34.93 |
| 医药制剂(%) | 2.76 | 2.76 |
| 其他(%) | 0.13 | - |
| 毛利构成(%) | ||
| 动保添加剂及制剂(%) | 1.60 | 2.05 |
| 动保原料药(%) | 27.33 | 24.03 |
| 关键医药中间体(%) | 30.81 | 40.46 |
| 医药原料药(%) | 38.80 | 32.53 |
| 医药制剂(%) | 1.46 | 0.93 |
| 其他(%) | -0.01 | - |